Gilead's Livdelzi\u00ae (Seladelpar) Demonstrated Consistent Efficacy and Safety Regardless of Prior Treatment History in New Da

• click to rate

  Posted by Two Blokes May 7 - Filed in Stock - 4 views
  
  FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced new data from multiple analyses which reinforce that Livdelzi\u00ae (seladelpar), known as Lyvdelzi\u00ae in the European Union, is effective and generally well-tolerated for the treatment of primary biliary cholangitis (PBC) and also provides sustained biochemical response in adults with PBC regardless of prior treatment history. Another analysis provides evidence supporting that Livdelzi delivered clinically and.